BioSpace News Archive

Alzamend Neuro, Inc. today announced receipt of a “Study May Proceed” letter from the U.S. Food and Drug Administration (“FDA”) for the initiation of study AL001-PTSD01, a Phase IIA clinical study of AL001 for treatment of patients with PTSD.

Takara Bio USA, Inc. announced that it has once again prevailed in its second patent dispute with Jumpcode Genomics, Inc.

Veradigm Inc. announced today that it will now offer a conversational artificial intelligence (AI) agent for Practice Fusion Billing Services, a Veradigm Network solution.

Know Labs, Inc. today announced it will host a webcast to review business updates and results for its fiscal year ended on September 30, 2023, on December 19, 2023, beginning at 1:30 pm PT.

BioNTX, a leading organization in the bioscience industry, is thrilled to support DFW Airport’s announcement of the upcoming 2024 edition of the Pharma Logistics Masterclass at Pegasus Park.

ME Therapeutics Holdings Inc. (CSE: METX), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, is pleased to announce that the Company’s common shares are now listed on the Frankfurt Stock Exchange (FSE) under the symbol Q9T.

The global tissue diagnostics market size was valued at USD 4.75 billion in 2022 and is projected to surpass around USD 9.04 billion by 2032, expanding at a remarkable CAGR of 6.7% from 2023 to 2032.

Disc Medicine, Inc. (NASDAQ:IRON), today announced data from initial dose cohorts of its ongoing phase 1b/2 study of DISC-0974, a monoclonal antibody designed to suppress hepcidin by inhibiting the hemojuvelin (HJV) co-receptor, in MF patients with anemia.

Immodulon, a late-stage clinical biotechnology company focused on developing a broad spectrum immunomodulator to improve the lives of patients suffering from difficult-to-treat cancers, today announced the formation of a new Scientific Advisory Board comprising leading global experts in the field of clinical oncology.

Gilead Sciences, Inc. announced the company has once again been recognized as one of the most sustainable pharmaceutical companies according to the Dow Jones Sustainability World Index for the third consecutive year.